Categories AlphaGraphs, Earnings, Health Care

Trxade (MEDS) beats market expectations on Q1 revenue

Trxade (NASDAQ: MEDS) on Monday posted a 39% increase in first-quarter revenues to $3.1 million due to higher sales in the Integra Pharma Solutions unit. This was better than what analysts had anticipated.

Meanwhile, the company swung to a net loss of $0.08 per share from a profit last year due to higher costs associated with PPE. Analysts had anticipated a loss of $0.05 per share.

Trxade Q1 2021 earnings

CEO Suren Ajjarapu said in a statement, “We believe we are incredibly well positioned as we stand today, poised to monetize several emerging revenue streams in addition to the steady progress made by our high-margin Trxade Exchange core platform. I look forward to aggressive operational execution in the months ahead as we seek to create sustainable, long-term value for our shareholders.”

MEDS stock was up 4.7% during after-market hours on the stronger-than-expected revenues. The stock has declined 12% since the beginning of this year.

In the first quarter, the Tampa, Florida-based firm added 223 new independent pharmacies to its network. The company now has over 12,100 registered pharmacy members.

Trxade, which brings together independent pharmacies under one umbrella through its web-based purchasing platform, is present in all 50 states and is rapidly adding pharmacies to its network.

Prior performance

  • Trxade Q4 2020 earnings
  • Trxade Group Q3 2020 earnings
  • Trxade Group Q2 2020 earnings results.
  • Trxade Group Q1 2020 earnings

Most Popular

Earnings calendar for the week of May 3

Leading stock indexes retreated after gaining mid-week when Wall Street biggies like Apple and Amazon reported impressive quarterly numbers. The Dow Jones Industrial Average was down 190 early Friday, while

How did the first quarter of 2021 turn out for the airline industry?

The airlines sector was severely impacted by the disruption caused by the COVID-19 pandemic in 2020. A year later, the industry is still limping its way to a recovery. In

Amazon (AMZN) fine-tunes growth strategy to stay in the fast lane

The company that witnessed the strongest growth during the pandemic is probably, Inc. (NASDAQ: AMZN), which went into overdrive when the crisis triggered an online shopping boom. Taking a

Add Comment
Viewing Highlight